» Articles » PMID: 28812219

Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence

Overview
Publisher Springer
Specialty Cell Biology
Date 2017 Aug 17
PMID 28812219
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

In the recent times, stem cell biology has garnered the attention of the scientific fraternity and the general public alike due to the immense therapeutic potential that it holds in the field of regenerative medicine. A breakthrough in this direction came with the isolation of stem cells from human embryo and their differentiation into cell types of all three germ layers. However, the isolation of mesenchymal stem cells from adult tissues proved to be advantageous over embryonic stem cells due to the ethical and immunological naivety. Mesenchymal Stem Cells (MSCs) isolated from the bone marrow were found to differentiate into multiple cell lineages with the help of appropriate differentiation factors. Furthermore, other sources of stem cells including adipose tissue, dental pulp, and breast milk have been identified. Newer sources of stem cells have been emerging recently and their clinical applications are also being studied. In this review, we examine the eminent sources of Mesenchymal Stem Cells (MSCs), their immunophenotypes, and therapeutic imminence.

Citing Articles

Gingival Mesenchymal Stem Cells: A Periodontal Regenerative Substitute.

Shetty S, Sowmya S, Pradeep A, Jayakumar R Tissue Eng Regen Med. 2024; 22(1):1-21.

PMID: 39607668 PMC: 11711796. DOI: 10.1007/s13770-024-00676-8.


Advances in therapies using mesenchymal stem cells and their exosomes for treatment of peripheral nerve injury: state of the art and future perspectives.

Aldali F, Deng C, Nie M, Chen H Neural Regen Res. 2024; 20(11):3151-3171.

PMID: 39435603 PMC: 11881730. DOI: 10.4103/NRR.NRR-D-24-00235.


Ameliorative effects of undifferentiated and differentiated BM-MSCs in MIA-induced osteoarthritic Wistar rats: roles of NF-κB and MMPs signaling pathways.

Saleh A, Abdel-Gabbar M, Gabr H, Shams A, Tamur S, Mahdi E Am J Transl Res. 2024; 16(7):2793-2813.

PMID: 39114694 PMC: 11301505. DOI: 10.62347/FGHV2647.


Anaesthetics reduce the viability of adipose-derived stem cells.

Bugajska-Liedtke M, Fatyga N, Brzozowski A, Bajek A, Maj M Adipocyte. 2024; 13(1):2351870.

PMID: 38779963 PMC: 11123512. DOI: 10.1080/21623945.2024.2351870.


Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.

Hetta H, Elsaghir A, Sijercic V, Akhtar M, Gad S, Moses A Health Sci Rep. 2024; 7(4):e2036.

PMID: 38650719 PMC: 11033295. DOI: 10.1002/hsr2.2036.


References
1.
Wang J, Liu X, Jin X, Ma H, Hu J, Ni L . The odontogenic differentiation of human dental pulp stem cells on nanofibrous poly(L-lactic acid) scaffolds in vitro and in vivo. Acta Biomater. 2010; 6(10):3856-63. PMC: 3885689. DOI: 10.1016/j.actbio.2010.04.009. View

2.
Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N . Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS One. 2015; 10(8):e0136145. PMC: 4546614. DOI: 10.1371/journal.pone.0136145. View

3.
Wang Y, Han Z, Ma J, Zuo C, Geng J, Gong W . A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev. 2011; 21(9):1401-8. DOI: 10.1089/scd.2011.0441. View

4.
Zucconi E, Vieira N, Bueno Jr C, Secco M, Jazedje T, Costa Valadares M . Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy. J Biomed Biotechnol. 2011; 2011:715251. PMC: 3139201. DOI: 10.1155/2011/715251. View

5.
Zhou B, Yuan J, Zhou Y, Ghawji Jr M, Deng Y, Lee A . Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol. 2011; 141(3):328-37. DOI: 10.1016/j.clim.2011.08.014. View